slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
70,5 TWD | +1,29% | +0,57% | -19,89% |
Vakgebied
Verkoop per activiteit
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
New Drug Development
100,0
%
| 0 | nan % | 315 | 100,0 % | - |
Verkoop per regio
TWD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| - | - | 315 | 100,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pei Kan
CEO | Chief Executive Officer | - | 01-04-18 |
Shu Ping Yang
DFI | Director of Finance/CFO | - | 01-06-15 |
Ko Chieh Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Hui An Pao
COO | Chief Operating Officer | - | 19-09-16 |
Ju Yi Lin
ADM | Chief Administrative Officer | 58 | 01-06-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Li Jen Wu
BRD | Director/Board Member | - | 10-01-22 |
Ko Jui Shih
BRD | Director/Board Member | - | 25-10-21 |
Wen Chang Chang
BRD | Director/Board Member | - | 10-01-22 |
Chien Chih Wang
CHM | Chairman | - | 21-06-16 |
Yan Ling Fang
BRD | Director/Board Member | 66 | 10-01-22 |
Pei Kan
CEO | Chief Executive Officer | - | 01-04-18 |
Wen Hsu Yan
BRD | Director/Board Member | - | - |
Chi Heng Chien
BRD | Director/Board Member | - | - |
Te Chun Kung
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 129 018 004 | 79 397 004 ( 61,54 %) | 0 | 61,54 % |
Bedrijfsgegevens
Pharmosa Biopharm, Inc.
3/F-3, 66 Sanchong Road Nangang District
115602, Taipei
+
http://www.pharmosa.com.twSector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,89% | 281 mln. | |
+37,76% | 52,5 mld. | |
-7,47% | 39,01 mld. | |
+37,72% | 39,31 mld. | |
+11,93% | 26,2 mld. | |
-11,17% | 26,57 mld. | |
+16,45% | 28,2 mld. | |
+45,05% | 14,15 mld. | |
+33,13% | 12,62 mld. | |
-3,46% | 11,74 mld. |
- Beurs
- Aandelen
- Koers 6875
- Onderneming Pharmosa Biopharm Inc.